查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1756491

RSV 診斷市場（按產品、按方法、按最終用戶、按國家和地區）- 2024 年至 2032 年行業分析、市場規模、市場佔有率及預測

RSV Diagnostics Market, By Product, By Method, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 356 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年 RSV 診斷市場規模價值為 6,4566.7 億美元，2024 年至 2032 年的複合年成長率為 5.87%。

呼吸道合胞病毒 (RSV) 診斷市場-市場動態

呼吸道感染盛行率不斷上升

呼吸道感染發生率的上升，尤其是在嬰兒、老年人和免疫功能低下患者群體中，是呼吸道合胞病毒 (RSV) 診斷市場的主要驅動力。呼吸道合胞病毒 (RSV) 是全球下呼吸道感染的主要原因，導致大量住院和醫療費用增加。透過先進的 RSV 診斷工具進行早期準確診斷有助於及時治療並減少感染傳播。此外，醫療保健提供者意識的提高以及診斷技術可近性的提高進一步推動了市場成長。這些因素共同推動了全球對高效快速 RSV 診斷解決方案的需求。

RSV 診斷市場—關鍵見解

根據我們的研究分析師，全球 RSV 診斷市場預計在 2024 年至 2032 年期間以約 5.87% 的複合年成長率發展。

2024 年按產品細分，試劑盒和檢測類別佔據了市場主導地位。

根據最終用戶，醫院和診所部門在 2024 年創造了最多的收入。

按地區分類，2024年北美是收入最高的地區。

RSV 診斷市場-細分分析：

全球 RSV 診斷市場分為四大類：產品、方法、最終用戶和地區。

依產品分類，呼吸道合胞病毒 (RSV) 診斷市場分為試劑盒及檢測試劑、儀器及其他產品。試劑盒及檢測試劑包括用於檢測病患檢體中 RSV 抗原或核酸的試劑及檢測試劑盒。儀器是指用於進行診斷測試的設備和分析儀，例如 PCR 儀和免疫測定讀數儀。其他產品包括測試過程中所需的耗材和配件。在這些細分市場中，試劑盒及檢測試劑佔據主導地位，因為它們在提供快速且準確的結果方面發揮關鍵作用，這對於及時的臨床決策至關重要。試劑盒的便利性、易用性和檢測技術的進步推動了醫院、診所和診斷實驗室對試劑盒的廣泛採用，使其成為 RSV 診斷市場最大的收入貢獻者。

按最終用戶分類，呼吸道合胞病毒 (RSV) 診斷市場可細分為醫院和診所、臨床實驗室和家庭護理。醫院和診所是患者直接接受診斷和治療的醫療機構，通常處理大量呼吸道病例。臨床實驗室專門進行診斷檢測，配備先進設備和熟練的人員，為多家醫療機構提供服務。居家照護涉及居家檢測解決方案，可在傳統醫療機構之外提供便利的早期檢測服務。其中，醫院和診所因其在患者護理中發揮一線作用而佔據市場主導地位，尤其是在呼吸道合胞病毒 (RSV) 疫情高發生季節，呼吸道感染激增。他們需要快速、準確的診斷來控制疫情並立即提供治療，這推動了對 RSV 診斷產品的巨大需求，使其成為市場上最大、影響力最大的最終用戶群。

呼吸道合胞病毒 (RSV) 診斷市場—地理洞察

從地理分佈來看，呼吸道合胞病毒 (RSV) 診斷市場分佈於北美、亞太地區、拉丁美洲、歐洲、中東和非洲。這些地區根據業務來源國進一步分類。

北美在呼吸道合胞病毒（RSV）診斷市場佔據主導地位，這得益於先進的醫療基礎設施、創新診斷技術的廣泛應用以及高昂的醫療支出。該地區RSV感染負擔沉重，尤其是在嬰幼兒和老年人群中，因此對精準快速檢測的需求日益成長。此外，強力的政府支持、完善的報銷政策以及領先的市場參與者的存在，也促進了市場的強勁成長。醫療服務提供者和患者對RSV早期診斷重要性的認知不斷提高，進一步推動了北美市場的擴張。

亞太地區是呼吸道合胞病毒（RSV）診斷市場的另一個主導地區，其龐大的患者群體和不斷上升的呼吸道感染發病率推動了這個市場的發展。快速的城市化、醫療設施的改善以及醫療基礎設施投資的增加，促進了RSV診斷解決方案的普及。中國、印度和日本等國家是RSV診斷解決方案的主要貢獻者，這得益於政府日益加強的傳染病防治措施。此外，城鄉地區診斷檢測意識的提高和可近性的提升也推動了市場的成長，使亞太地區成為全球RSV診斷領域中關鍵且快速成長的市場。

RSV 診斷市場-競爭格局：

呼吸道合胞病毒（RSV）診斷市場由專注於提高準確性和快速檢測的成熟診斷公司和創新新進入者共同構成​​。雅培、羅氏、賽默飛世爾和碧迪等主要參與者憑藉種類繁多的高品質診斷試劑盒、儀器和檢測試劑佔據市場主導地位。這些公司在研發方面投入巨資，以提高檢測靈敏度、縮短週轉時間並符合嚴格的監管標準。新興公司正在推出新型分子和即時檢測解決方案，加劇了競爭。這種動態促進了持續創新，擴大了RSV診斷在醫院、診所和實驗室的應用，從而改善了全球呼吸道感染管理。

最新動態：

2024 年 4 月，雅培推出了針對呼吸道合胞病毒和流感的下一代即時分子檢測，可更快、更準確地診斷呼吸道感染，從而支持在不同的臨床環境中獲得更好的患者治療結果。

2023 年 6 月，BD 完成了將其手術器械和腹腔鏡器械業務出售給 STERIS plc 的交易，從而精簡了其產品組合，專注於核心診斷和醫療設備領域。

目錄

第 1 章：呼吸道合胞病毒診斷市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • RSV 診斷市場（按產品）摘要
    • 呼吸道合胞病毒 (RSV) 診斷市場片段（依方法）
    • RSV 診斷市場片段（按最終用戶）
    • 呼吸道合胞病毒 (RSV) 診斷市場（按國家/地區）
    • 呼吸道合胞病毒 (RSV) 診斷市場（按地區）
  • 競爭洞察

第 3 章：呼吸道合胞病毒診斷關鍵市場趨勢

  • 呼吸道合胞病毒診斷市場促進因素
    • 市場促進因素的影響分析
  • 呼吸道合胞病毒診斷市場限制
    • 市場限制的影響分析
  • 呼吸道合胞病毒診斷市場機會
  • 呼吸道合胞病毒診斷市場未來趨勢

第4章：呼吸道合胞病毒診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：呼吸道合胞病毒診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長細分市場
    • 最鬆散的細分市場
    • 邊際損失市場區隔

第6章：呼吸道合胞病毒診斷市場格局

  • 2023 年呼吸道合胞病毒 (RSV) 診斷市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：呼吸道合胞病毒診斷市場 - 按產品

  • 概述
    • 按產品細分的市佔率分析
    • 試劑盒和檢測試劑
    • 儀器
    • 其他產品

第 8 章：呼吸道合胞病毒 (RSV) 診斷市場 - 依方法

  • 概述
    • 依方法細分市場佔有率分析
    • 分子診斷
    • 快速抗原檢測
      • 酵素連結免疫吸附試驗
      • 免疫螢光試驗
      • 其他快速抗原檢測
      • 色譜免疫分析
      • 光學免疫分析
    • 其他方法

第 9 章：呼吸道合胞病毒診斷市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院和診所
    • 臨床實驗室
    • 居家護理

第 10 章：呼吸道合胞病毒 (RSV) 診斷市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美呼吸道合胞病毒診斷主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品）
    • 北美市場規模和預測（按方法）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲呼吸道合胞病毒診斷主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品）
    • 歐洲市場規模與預測（按方法）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區呼吸道合胞病毒診斷主要製造商
    • 亞太市場規模及預測（按國家/地區）
    • 亞太市場規模及預測（按產品）
    • 亞太市場規模及預測（依方法）
    • 亞太市場規模及預測（依最終用戶）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲呼吸道合胞病毒診斷主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品）
    • 拉丁美洲市場規模與預測（按方法）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲呼吸道合胞病毒診斷主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模和預測（按方法）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：RSV 診斷產業關鍵供應商分析

  • 競爭儀錶板
  • 公司簡介
    • Biomerieux
    • Becton, Dickinson and Company (BD)
    • Abbott
    • Roche
    • Danaher
    • Thermo Fisher
    • Biocartis
    • Luminex
    • Hologic
    • Fast Track Diagnostics
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5247

REPORT HIGHLIGHT

RSV Diagnostics Market size was valued at USD 6,456.67 Billion in 2024, expanding at a CAGR of 5.87% from 2024 to 2032.

Respiratory Syncytial Virus (RSV) diagnostics involve detecting the presence of RSV infection in patients, primarily through respiratory samples like nasal swabs. The main diagnostic methods include nucleic acid amplification tests (NAATs) such as real-time PCR, which are highly sensitive and specific, rapid antigen detection tests (RADTs) that provide quicker but sometimes less accurate results, and viral culture, which is slower and less commonly used. Accurate detection is crucial for timely treatment and infection control, especially in infants and elderly patients vulnerable to severe RSV disease. Testing is usually performed within the early days of symptom onset to ensure reliability.

RSV Diagnostics Market- Market Dynamics

Increasing Prevalence of Respiratory Infections

The rising incidence of respiratory infections, particularly among infants, elderly individuals, and immunocompromised patients, is a major driver for the RSV diagnostics market. Respiratory Syncytial Virus (RSV) is a leading cause of lower respiratory tract infections worldwide, resulting in significant hospitalizations and healthcare costs. Early and accurate diagnosis through advanced RSV diagnostic tools helps in timely treatment and reduces the spread of infection. Additionally, growing awareness among healthcare providers and improved access to diagnostic technologies further fuel market growth. These factors collectively boost demand for efficient and rapid RSV diagnostic solutions globally.

RSV Diagnostics Market- Key Insights

According to our research analyst, the global RSV Diagnostics Market is expected to develop at a CAGR of approximately 5.87% between 2024-2032.

Segmented by Product in 2024, the Kits and Assays category dominated the market.

Based on End User, the Hospitals and Clinics segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

RSV Diagnostics Market- Segmentation Analysis:

The global RSV Diagnostics Market is divided into Four categories: Product, Method, End User and Region.

By product, the RSV diagnostics market is segmented into Kits and Assays, Instruments, and Other Products. Kits and Assays include reagents and test kits used for detecting RSV antigens or nucleic acids in patient samples. Instruments refer to the devices and analyzers used to perform diagnostic tests, such as PCR machines and immunoassay readers. Other Products encompass consumables and accessories required during testing. Among these segments, Kits and Assays hold the dominant share due to their critical role in providing rapid and accurate results, which are essential for timely clinical decision-making. The convenience, ease of use, and advancements in assay technologies have driven strong adoption of kits across hospitals, clinics, and diagnostic laboratories, making this segment the largest revenue contributor in the RSV diagnostics market.

By end user, the RSV diagnostics market is segmented into Hospitals and Clinics, Clinical Laboratories, and Home Care. Hospitals and Clinics represent healthcare facilities where patients receive diagnosis and treatment directly, often handling a high volume of respiratory cases. Clinical Laboratories specialize in conducting diagnostic tests with advanced equipment and skilled personnel, serving multiple healthcare providers. Home Care involves at-home testing solutions that offer convenience and early detection outside traditional healthcare settings. Among these, Hospitals and Clinics dominate the market due to their frontline role in patient care, especially during RSV seasons when respiratory infections surge. Their need for rapid, accurate diagnostics to manage outbreaks and provide immediate treatment drives substantial demand for RSV diagnostic products, making them the largest and most influential end-user segment in the market.

RSV Diagnostics Market- Geographical Insights

Geographically, the RSV Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds a dominant position in the RSV diagnostics market, driven by advanced healthcare infrastructure, widespread adoption of innovative diagnostic technologies, and high healthcare spending. The region experiences a significant burden of RSV infections, especially among infants and elderly populations, increasing demand for accurate and rapid testing. Additionally, strong government support, well-established reimbursement policies, and presence of leading market players contribute to robust market growth. The growing awareness among healthcare providers and patients about the importance of early RSV diagnosis further fuels the expansion of the market in North America.

Asia Pacific is another dominant region in the RSV diagnostics market, propelled by a large patient population and rising incidence of respiratory infections. Rapid urbanization, improving healthcare facilities, and increasing investments in healthcare infrastructure enhance the adoption of RSV diagnostic solutions. Countries such as China, India, and Japan are key contributors, supported by growing government initiatives to combat infectious diseases. Additionally, increasing awareness and accessibility to diagnostic testing in both urban and rural areas are driving market growth, making Asia Pacific a critical and fast-growing segment in the global RSV diagnostics landscape.

RSV Diagnostics Market- Competitive Landscape:

The RSV diagnostics market is shaped by established diagnostics firms and innovative newcomers focusing on enhanced accuracy and rapid detection. Key players such as Abbott, Roche, Thermo Fisher, and Becton Dickinson dominate the market with a wide range of high-quality diagnostic kits, instruments, and assays. These companies invest heavily in R&D to improve test sensitivity, reduce turnaround time, and comply with stringent regulatory standards. Emerging companies are introducing novel molecular and point-of-care testing solutions, increasing competition. This dynamic fosters continuous innovation, expanding the adoption of RSV diagnostics across hospitals, clinics, and laboratories, thereby improving respiratory infection management globally.

Recent Developments:

In April 2024, Abbott launched a next-generation point-of-care molecular test for RSV and influenza, delivering faster and more accurate respiratory infection diagnosis to support better patient outcomes in diverse clinical settings.

In June 2023, BD completed the sale of its surgical instruments and laparoscopic instrumentation business to STERIS plc, streamlining its portfolio to focus on core diagnostic and medical device segments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RSV DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Biomerieux
  • Becton, Dickinson and Company (BD)
  • Abbott
  • Roche
  • Danaher
  • Thermo Fisher
  • Biocartis
  • Luminex
  • Hologic
  • Fast Track Diagnostics
  • Others

GLOBAL RSV DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Kits and Assays
  • Instruments
  • Other Products

GLOBAL RSV DIAGNOSTICS MARKET, BY METHOD - MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Rapid Antigen Detection Tests
  • Enzyme-Linked Immunosorbent Assays
  • Immunofluorescence Assays
  • Other Rapid Antigen Detection Tests
  • Chromatographic Immunoassays
  • Optical Immunoassays
  • Other Methods

GLOBAL RSV DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Clinical Laboratories
  • Home Care

GLOBAL RSV DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. RSV Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RSV Diagnostics Market Snippet by Product
    • 2.1.2. RSV Diagnostics Market Snippet by Method
    • 2.1.3. RSV Diagnostics Market Snippet by End User
    • 2.1.4. RSV Diagnostics Market Snippet by Country
    • 2.1.5. RSV Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. RSV Diagnostics Key Market Trends

  • 3.1. RSV Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RSV Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RSV Diagnostics Market Opportunities
  • 3.4. RSV Diagnostics Market Future Trends

4. RSV Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RSV Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RSV Diagnostics Market Landscape

  • 6.1. RSV Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RSV Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Kits and Assays
    • 7.1.3. Instruments
    • 7.1.4. Other Products

8. RSV Diagnostics Market - By Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Method, 2023 & 2032 (%)
    • 8.1.2. Molecular Diagnostics
    • 8.1.3. Rapid Antigen Detection Tests
      • 8.1.3.1. Enzyme-Linked Immunosorbent Assays
      • 8.1.3.2. Immunofluorescence Assays
      • 8.1.3.3. Other Rapid Antigen Detection Tests
      • 8.1.3.3.1. Chromatographic Immunoassays
      • 8.1.3.3.2. Optical Immunoassays
    • 8.1.4. Other Methods

9. RSV Diagnostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Clinical Laboratories
    • 9.1.4. Home Care

10. RSV Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. RSV Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. RSV Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. RSV Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. RSV Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. RSV Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- RSV Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biomerieux
    • 11.2.2. Becton, Dickinson and Company (BD)
    • 11.2.3. Abbott
    • 11.2.4. Roche
    • 11.2.5. Danaher
    • 11.2.6. Thermo Fisher
    • 11.2.7. Biocartis
    • 11.2.8. Luminex
    • 11.2.9. Hologic
    • 11.2.10. Fast Track Diagnostics
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us